From SCAI in Las Vegas: Diabetes and STEMI
CardioSource Interventional News—For patients with ST-elevation myocardial infarction (STEMI), in-hospital mortality has declined steadily in recent years. A new analysis of more than 300,000 people entered into the Nationwide Inpatient Sample database indicates that this is true for patients whether they have type 2 diabetes or not at hospital entry.
The reduction in mortality is greater for patients without diabetes (down 56.4% for STEMI patients without diabetes versus 39.6% for individuals with diabetes). Plus, despite the improvement, there remains a big 4-fold difference in risk. Still, age-adjusted in-hospital mortality for patients with diabetes and STEMI has dropped from 469 deaths per 100,000 in 1988 to 283 per 100,000 in 2006. For individuals presenting with STEMI but without type 2 diabetes, in-hospital mortality has fallen from 124 to 54 per 100,000 over the same period.
The data by Mohammad Reza Movahed, MD, PhD, et al. suggest that persistent advancement in the management of patients with diabetes has been associated with better outcomes and this improvement was evident regardless of comorbidity.